anesthesia glp-1 news π΄ RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx
Pay in 4 interest-free payments of $5.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://image.slidesharecdn.com/glp-1ras-and-anesthesia-a-guide-to-safe-practicesautosaved-251022071155-f92d8e2f/75/GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices-Autosaved-pptx-10-2048.jpg)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://i.ytimg.com/vi/-lvqfmRTH0E/mqdefault.jpg)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://www.uchicagomedicine.org/_next/image?url=https%3A%2F%2Fedge.sitecorecloud.io%2Funichicagomc-81nbqnb3%2Fmedia%2Fimages%2Fucmc%2Fforefront%2Fchannel-pages%2Fresearch-and-discoveries%2Funiversal%2Fglp-1-drug-universal-832x469.jpg&w=3840&q=75)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://www.anesthesiologynews.com/aimages/2025/AN0625_022_105591_blurb_lead.jpg)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://media.wzzm13.com/assets/WZZM/images/91e60b55-27bc-4104-8878-63c7568be23f/20260728T221709/91e60b55-27bc-4104-8878-63c7568be23f_1920x1080.jpg)






















